Sally Davies
UK Special Envoy on Antimicrobial Resistance; Former Chief Medical Officer (CMO) for England; Former Chief Medical Adviser to the UK government

about me

Dame Sally Davies was appointed as the UK Government's Special Envoy on AMR in 2019. She is also the 40th Master of Trinity College, Cambridge University. Dame Sally was the Chief Medical Officer for England and Senior Medical Advisor to the UK Government from 2011-2019. She is a leading figure in global health, having served as a member of the World Health Organisation (WHO) Executive Board 2014-2016, and as co-convener of the United Nations Inter-Agency Co-ordination Group (IACG) on Antimicrobial Resistance (AMR), reporting in 2019. In November 2020, Dame Sally was announced as a member of the new UN Global Leaders Group on AMR, serving alongside Heads of State, Ministers and prominent figures from around the world to advocate for action on AMR. In the 2020 New Year Honours, Dame Sally became the second woman (and the first outside the Royal family) to be appointed Dame Grand Cross of the Order of the Bath (GCB) for services to public health and research, having received her DBE in 2009.

more fellows

SUI
Dunja Nicca
University of Zürich
Dunja Nicca
Research Group Leader and Head, Advanced Practices Nurses (APN), Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Switzerland
GBR
Lawrence Tallon
Guy's and St Thomas' NHS Foundation Trust
Lawrence Tallon
Chief Executive Officer, Medicines and Healthcare products Regulatory Agency, United Kingdom
GBR
Rishi Das Gupta
Health Innovation Network (HIN)
Rishi Das Gupta
Chief Executive, Health Innovation Network (HIN), United Kingdom
GBR
Judith Proctor
Edinburgh Integration Joint Board
Judith Proctor
Chief Officer, Edinburgh Integration Joint Board, Scotland, United Kingdom
SUI
Mario Desmedt
Swiss Nurse Leaders
Mario Desmedt
Nurse; Director of Nursing, Fondation Asile des Aveugles, Lausanne; President, Swiss Nurse Leaders Association, Switzerland
GER
Wiebke Loebker
Federal Institute of Drugs and Medical Product
Wiebke Loebker
Personal Assistant of the President; Federal Institute of Drugs and Medical Products; Head of Innovation Office, Change Management Staff Unit, Germany
GER
Thorsten Langer
University of Freiburg, Medical Center
Thorsten Langer
Professor, Director Social Pediatric Center, Children's Hospital Freiburg, Germany
GBR
Adrian Jonas
NHS England
Adrian Jonas
Chief Analyst for the North West Region, NHS England, United Kingdom
GER
Michael Moran
AbbVie GmbH & Co. KG
Michael Moran
Medical Director and Therapeutic Area Lead, Global Medical Affairs, AbbVie GmbH & Co. KG, Germany
GBR
Rupert Suckling
Doncaster Council
Rupert Suckling
Director of Public Health, Doncaster Council in the North of England; Board Member, Association of Directors of Public Health, UK
SUI
Ursula Bonhage
Stiftung Stöckenweid
Ursula Bonhage
CEO, Stiftung Stöckenweid
SUI
Nicola von Lutterotti
Self-employed
Nicola von Lutterotti
President of the Board of Trustees, the Max-Planck Institute for Immunobiology and Epigenetics, Freiburg; Science Writer; Author, Germany
GBR
Helen Crimlisk
Sheffield Health & Social Care NHS Foundation Tr
Helen Crimlisk
Consultant Psychiatrist and Deputy Medical Director, Sheffield Health and Social Care NHS Foundation Trust, United Kingdom
SUI
Claudia Witt
University of Zurich
Claudia Witt
Professor of Medicine, University of Zurich; Director, Institute for Complementary and Integrative Medicine; University Hospital Zurich, Switzerland
SUI
Oliver Reich
SWICA Health Organisation
Oliver Reich
Director, santé24, Switzerland
GER
Kristina Norman
German Institute of Human Nutrition
Kristina Norman
Professor for Nutrition and Gerontology , German Institute for Human Nutrition (DIfE) and Department of Geriatrics, Charite Universitätsmedizin Berlin, Germany

Meet the Partners

Sciana: The Health Leaders Network is a programme supported jointly by the Health Foundation (UK), Careum (CH) and the Bosch Health Campus (DE) in collaboration with Salzburg Global.